While it might sound like a New Age dream that a shrub known as “holy herb” from California could help treat Alzheimer’s, it’s not so…
First it was a diabetes drug, now researchers have turned their attention to an HIV drug. Could a drug that would slow down Alzheimer’s…
A recent study shows that a decline in electrical activity in the brain could be a marker of Alzheimer’s and primary progressive aphasia. If…
Does a drug that could treat Alzheimer’s already exist? A new study suggests that people with Alzheimer’s given a diabetes drug had fewer signs…
Inside your brain, there are 100 billion cells carrying out the daily tasks of keeping you alive and feeding you information: transmitting messages from…
Alzheimer’s is a complex disease, baffling researchers for decades as they’ve tried to unravel its cause and potential treatments, but this week saw fresh…
Could an ultrasound unlock the secret to curing Alzheimer’s? Results from a recent study show that using the sound waves emitted by an ultrasound…
The long search for a drug to slow the decline of Alzheimer’s may have reached a turning point. Pharmaceutical companies Biogen and Eisai have…
After years of failure, including some pharmaceutical companies calling off Alzheimer’s research altogether, Biogen offers a glimmer of hope: New data from a Phase…
Do you ever wonder why you feel so good when you hear an old favorite song you know all the words to, but you…
Scientists highlight that targeting amyloid early on in patients’ progression of Alzheimer’s is key to treating the disease effectively. By the time a patient…
When LaVonne Moore, 85, entered Ohio State University’s Wexner Medical Center study on slowing the decline of problem solving in Alzheimer’s patients, she had lost…
The leading theory in Alzheimer’s disease is that memory loss is the result of neuron death and nerve ending damage, which lead to memory…
Scientists looking for a new Alzheimer’s treatment have traditionally focused on the build-up of protein deposits such as beta-amyloid and tau in patients’ brains….
Being Patient meets John Gallacher, Professor of Cognitive Health at Oxford University and Director of the Dementias Platform UK (DPUK), to find out how…